ScholarIQanswers from OpenAlex
Universities UK
InstitutionResearch output, impact & collaborations
Universities UK is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universities UK?
ScholarIQrecord summary
Universities UK is a research organisation in London, GB. OpenAlex records 4,803 works and 175,980 citations for it. 683 researchers list it as their most recent affiliation.
How many works does Universities UK have?
ScholarIQindexed works
Universities UK has 4,803 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universities UK have?
ScholarIQcitation count
Universities UK has 175,980 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universities UK?
ScholarIQresearcher count
Universities UK has 683 researchers in the ScholarIQ index.
What is the average h-index at Universities UK?
ScholarIQavg h-index
Universities UK has an average h-index of 81.7 in OpenAlex.
What is the ROR of Universities UK?
ScholarIQror
The ROR for Universities UK is on the source record.
What is the OpenAlex record for Universities UK?
ScholarIQopenalex
The OpenAlex for Universities UK is on the source record.
Who are the most-cited researchers behind Universities UK?
ScholarIQtop researchers by citations
What are the most-cited papers on Universities UK?
ScholarIQmost cited works
Expanding the utilization of sustainable plant products in aquafeeds: a review
Delbert M. Gatlin, Frederic T. Barrows, Paul B. Brown, Konrad Dąbrowski, T. Gibson Gaylord, Ronald W. Hardy, Eliot M. Herman, Gongshe Hu, Åshild Krogdahl, Richard Nelson, K Overturf, Michael Rust, Wendy M. Sealey, Denise Skonberg, Edward Souza, David A. Stone, Rich Wilson, Eve Syrkin Wurtele
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
Brendan McAdam, Francesca Catella-Lawson, Issam A. Mardini, Shiv Kapoor, John A. Lawson, Garret A. FitzGerald
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis Dlugos, Noah Berkowitz, Maurizio Voi, Séverine Peyrard, Diana Pelov, David Neal Franz
Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
Maria B. Kadiiska, Beth C. Gladen, Donna D. Baird, Dori R. Germolec, LeRae Graham, Carol E. Parker, Abraham Nyska, J. T. Wachsman, B N Ames, Soumen Basu, N Brot, Garret A. FitzGerald, Robert A. Floyd, Magdalene M. George, Jay W. Heinecke, Gary E. Hatch, K. Hensley, John A. Lawson, L.J. Marnett, Jason D. Morrow, Deirdre M. Murray, John P. Plastaras, L. Jackson Roberts, Joshua Rokach, Mark K. Shigenaga, Rajindar S. Sohal, Jing Sun, Raymond R. Tice, David H. Van Thiel, Daniel Wellner, Patrick B. Walter, K. B. Tomer, Ronald P. Mason, J. Carl Barrett
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
Garret A. FitzGerald, John A. Oates, Jacek Hawiger, Richard L. Maas, L. Jackson Roberts, John A. Lawson, Alan Brash
How much of the research on Universities UK is open access?
ScholarIQopen access share
42%OPEN ACCESS